Intracranial Atherosclerotic Disease Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 76 pages | ID: I209040C3804EN
Market Monitor Global

Abstracts

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

This report contains market size and forecasts of Intracranial Atherosclerotic Disease Treatment in global, including the following market information:

Global Intracranial Atherosclerotic Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Intracranial Atherosclerotic Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Intracranial Atherosclerotic Disease Treatment companies in 2021 (%)

The global Intracranial Atherosclerotic Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intracranial Atherosclerotic Disease Treatment include Stryker, Balt, TERUMO, MicroPort and Acandis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intracranial Atherosclerotic Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intracranial Atherosclerotic Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Stent
• PTA Balloon

Global Intracranial Atherosclerotic Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Intracranial Atherosclerotic Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intracranial Atherosclerotic Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intracranial Atherosclerotic Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Intracranial Atherosclerotic Disease Treatment revenues share in global market, 2021 (%)

Key companies Intracranial Atherosclerotic Disease Treatment sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Intracranial Atherosclerotic Disease Treatment sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Stryker
• Balt
• TERUMO
• MicroPort
• Acandis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Intracranial Atherosclerotic Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Intracranial Atherosclerotic Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTRACRANIAL ATHEROSCLEROTIC DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Intracranial Atherosclerotic Disease Treatment Market Size: 2021 VS 2028
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Intracranial Atherosclerotic Disease Treatment Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Intracranial Atherosclerotic Disease Treatment Players in Global Market
3.2 Top Global Intracranial Atherosclerotic Disease Treatment Companies Ranked by Revenue
3.3 Global Intracranial Atherosclerotic Disease Treatment Revenue by Companies
3.4 Global Intracranial Atherosclerotic Disease Treatment Sales by Companies
3.5 Global Intracranial Atherosclerotic Disease Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Intracranial Atherosclerotic Disease Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Intracranial Atherosclerotic Disease Treatment Players in Global Market
  3.8.1 List of Global Tier 1 Intracranial Atherosclerotic Disease Treatment Companies
  3.8.2 List of Global Tier 2 and Tier 3 Intracranial Atherosclerotic Disease Treatment Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Intracranial Atherosclerotic Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Stent
  4.1.3 PTA Balloon
4.2 By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Intracranial Atherosclerotic Disease Treatment Sales & Forecasts
  4.3.1 By Type - Global Intracranial Atherosclerotic Disease Treatment Sales, 2017-2022
  4.3.2 By Type - Global Intracranial Atherosclerotic Disease Treatment Sales, 2023-2028
  4.3.3 By Type - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Intracranial Atherosclerotic Disease Treatment Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Intracranial Atherosclerotic Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Intracranial Atherosclerotic Disease Treatment Sales & Forecasts
  5.3.1 By Application - Global Intracranial Atherosclerotic Disease Treatment Sales, 2017-2022
  5.3.2 By Application - Global Intracranial Atherosclerotic Disease Treatment Sales, 2023-2028
  5.3.3 By Application - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Intracranial Atherosclerotic Disease Treatment Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Intracranial Atherosclerotic Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Intracranial Atherosclerotic Disease Treatment Sales & Forecasts
  6.3.1 By Region - Global Intracranial Atherosclerotic Disease Treatment Sales, 2017-2022
  6.3.2 By Region - Global Intracranial Atherosclerotic Disease Treatment Sales, 2023-2028
  6.3.3 By Region - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028
  6.4.2 By Country - North America Intracranial Atherosclerotic Disease Treatment Sales, 2017-2028
  6.4.3 US Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.4.4 Canada Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.4.5 Mexico Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028
  6.5.2 By Country - Europe Intracranial Atherosclerotic Disease Treatment Sales, 2017-2028
  6.5.3 Germany Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.4 France Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.5 U.K. Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.6 Italy Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.7 Russia Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.8 Nordic Countries Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.5.9 Benelux Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028
  6.6.2 By Region - Asia Intracranial Atherosclerotic Disease Treatment Sales, 2017-2028
  6.6.3 China Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.6.4 Japan Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.6.5 South Korea Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.6.6 Southeast Asia Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.6.7 India Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028
  6.7.2 By Country - South America Intracranial Atherosclerotic Disease Treatment Sales, 2017-2028
  6.7.3 Brazil Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.7.4 Argentina Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales, 2017-2028
  6.8.3 Turkey Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.8.4 Israel Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.8.5 Saudi Arabia Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028
  6.8.6 UAE Intracranial Atherosclerotic Disease Treatment Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Stryker
  7.1.1 Stryker Corporate Summary
  7.1.2 Stryker Business Overview
  7.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Major Product Offerings
  7.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Sales and Revenue in Global (2017-2022)
  7.1.5 Stryker Key News
7.2 Balt
  7.2.1 Balt Corporate Summary
  7.2.2 Balt Business Overview
  7.2.3 Balt Intracranial Atherosclerotic Disease Treatment Major Product Offerings
  7.2.4 Balt Intracranial Atherosclerotic Disease Treatment Sales and Revenue in Global (2017-2022)
  7.2.5 Balt Key News
7.3 TERUMO
  7.3.1 TERUMO Corporate Summary
  7.3.2 TERUMO Business Overview
  7.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Major Product Offerings
  7.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Sales and Revenue in Global (2017-2022)
  7.3.5 TERUMO Key News
7.4 MicroPort
  7.4.1 MicroPort Corporate Summary
  7.4.2 MicroPort Business Overview
  7.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Major Product Offerings
  7.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Sales and Revenue in Global (2017-2022)
  7.4.5 MicroPort Key News
7.5 Acandis
  7.5.1 Acandis Corporate Summary
  7.5.2 Acandis Business Overview
  7.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Major Product Offerings
  7.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Sales and Revenue in Global (2017-2022)
  7.5.5 Acandis Key News

8 GLOBAL INTRACRANIAL ATHEROSCLEROTIC DISEASE TREATMENT PRODUCTION CAPACITY, ANALYSIS

8.1 Global Intracranial Atherosclerotic Disease Treatment Production Capacity, 2017-2028
8.2 Intracranial Atherosclerotic Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Intracranial Atherosclerotic Disease Treatment Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 INTRACRANIAL ATHEROSCLEROTIC DISEASE TREATMENT SUPPLY CHAIN ANALYSIS

10.1 Intracranial Atherosclerotic Disease Treatment Industry Value Chain
10.2 Intracranial Atherosclerotic Disease Treatment Upstream Market
10.3 Intracranial Atherosclerotic Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Intracranial Atherosclerotic Disease Treatment Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Intracranial Atherosclerotic Disease Treatment in Global Market
Table 2. Top Intracranial Atherosclerotic Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Intracranial Atherosclerotic Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Intracranial Atherosclerotic Disease Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Intracranial Atherosclerotic Disease Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Intracranial Atherosclerotic Disease Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Intracranial Atherosclerotic Disease Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Intracranial Atherosclerotic Disease Treatment Product Type
Table 9. List of Global Tier 1 Intracranial Atherosclerotic Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intracranial Atherosclerotic Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Intracranial Atherosclerotic Disease Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales, (K Units), 2023-2028
Table 46. Stryker Corporate Summary
Table 47. Stryker Intracranial Atherosclerotic Disease Treatment Product Offerings
Table 48. Stryker Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Balt Corporate Summary
Table 50. Balt Intracranial Atherosclerotic Disease Treatment Product Offerings
Table 51. Balt Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. TERUMO Corporate Summary
Table 53. TERUMO Intracranial Atherosclerotic Disease Treatment Product Offerings
Table 54. TERUMO Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. MicroPort Corporate Summary
Table 56. MicroPort Intracranial Atherosclerotic Disease Treatment Product Offerings
Table 57. MicroPort Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Acandis Corporate Summary
Table 59. Acandis Intracranial Atherosclerotic Disease Treatment Product Offerings
Table 60. Acandis Intracranial Atherosclerotic Disease Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Intracranial Atherosclerotic Disease Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Intracranial Atherosclerotic Disease Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Intracranial Atherosclerotic Disease Treatment Production by Region, 2017-2022 (K Units)
Table 64. Global Intracranial Atherosclerotic Disease Treatment Production by Region, 2023-2028 (K Units)
Table 65. Intracranial Atherosclerotic Disease Treatment Market Opportunities & Trends in Global Market
Table 66. Intracranial Atherosclerotic Disease Treatment Market Drivers in Global Market
Table 67. Intracranial Atherosclerotic Disease Treatment Market Restraints in Global Market
Table 68. Intracranial Atherosclerotic Disease Treatment Raw Materials
Table 69. Intracranial Atherosclerotic Disease Treatment Raw Materials Suppliers in Global Market
Table 70. Typical Intracranial Atherosclerotic Disease Treatment Downstream
Table 71. Intracranial Atherosclerotic Disease Treatment Downstream Clients in Global Market
Table 72. Intracranial Atherosclerotic Disease Treatment Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Intracranial Atherosclerotic Disease Treatment Segment by Type
Figure 2. Intracranial Atherosclerotic Disease Treatment Segment by Application
Figure 3. Global Intracranial Atherosclerotic Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intracranial Atherosclerotic Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intracranial Atherosclerotic Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Intracranial Atherosclerotic Disease Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Intracranial Atherosclerotic Disease Treatment Revenue in 2021
Figure 9. By Type - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Intracranial Atherosclerotic Disease Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Intracranial Atherosclerotic Disease Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 19. US Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 24. Germany Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 33. China Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Intracranial Atherosclerotic Disease Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Intracranial Atherosclerotic Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Intracranial Atherosclerotic Disease Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Intracranial Atherosclerotic Disease Treatment by Region, 2021 VS 2028
Figure 50. Intracranial Atherosclerotic Disease Treatment Industry Value Chain
Figure 51. Marketing Channels